千红制药(002550.SZ)发布上半年业绩，归母净利润2.58亿元，增长41.17%

Group 1 - The core viewpoint of the article is that Qianhong Pharmaceutical (002550.SZ) reported its 2025 semi-annual results, showing a slight increase in revenue and a significant rise in net profit [1] Group 2 - The company's operating revenue for the first half of 2025 was 862 million yuan, representing a year-on-year growth of 0.72% [1] - The net profit attributable to shareholders of the listed company was 258 million yuan, reflecting a year-on-year increase of 41.17% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 199 million yuan, which is a year-on-year growth of 10.71% [1] - The basic earnings per share were 0.2065 yuan [1]